| Monday
25 February |
|||||
 |
|
||||
| 08.15 |
Registration |
||||
|
|
||||
09.00
|
BALLROOM Opening Welcome Edwards Angell Palmer & Dodge |
||||
|
|
||||
09.10 |
Keynote Address Dennis Purcell, Senior Managing Director, Aisling Capital |
||||
|
|
||||
09.30 |
Funding for the Biotech Industry
|
||||
|
|
||||
10.10 |
Coffee
Break |
||||
|
|
||||
10.30
|
Small-Cap Listed Company Presentations |
||||
|
|||||
10.30
|
|
||||
|
|
||||
10.45
|
|
||||
|
|
||||
11.00
|
|
||||
|
|
||||
11.15
|
|
||||
|
|
||||
11.30
|
|
||||
|
|
||||
11.45
|
|
||||
|
|
||||
12.00
|
|
||||
|
|
||||
12.15
|
|
||||
|
|
||||
12.30
|
|
||||
|
|
||||
12.45
|
Questions to Panelists |
||||
|
|
||||
13.00 |
Lunch |
||||
|
|
||||
14.15 |
Panel Discussion: Global Investor Trends
|
||||
|
|
||||
15.00
|
Company Presentations |
||||
|
|||||
|
|
||||
15.00
|
|
||||
|
|
||||
15.15 |
|
||||
|
|
||||
15.30
|
|
||||
|
|
||||
15.45
|
|
||||
|
|
||||
16.00
|
Questions to Panelists |
||||
|
|
||||
16.10 |
Panel Discussion: Next Generation Antibody Therapeutics
| ||||
|
|
||||
17.10 |
Panel Discussion: Investing in Medical Devices
| ||||
|
|
||||
18.00 |
Cocktail
Reception |
||||
|
|
||||
|
|
|||||
| Tuesday
26 February |
|||||
|
|
||||
| 08.15 |
Registration |
||||
|
|
||||
08.30
|
BALLROOM Opening Keynote: Designing the Future of Cancer Research at MIT Robert Urban, Executive Director, The David H. Koch Institute for Integrative Cancer Research |
||||
|
|
||||
08.50 |
Science Keynote: Cancer Metabolism Lewis C. Cantley, Professor of Systems Biology, Beth Israel Deaconess Medical Centre, Harvard Medical School |
||||
|
|
||||
09.10 |
Panel Discussion: Transatlantic Investing (US - Europe)
|
||||
|
|
||||
09.50 |
Panel Discussion: Partnering – Successful Strategic Alliances
|
||||
|
|
||||
10.35 |
Coffee
Break |
||||
|
|
||||
11.00 |
Big Pharma and VC Panel
|
||||
|
|
||||
11.45
|
Partnering Presentations (order of presentations subject to change)
|
||||
|
|
||||
11.45
|
Biogen Idec: Leslie Coney, Director Business Development |
||||
|
|
||||
12.00
|
Bristol-Myers Squibb: Robert Schwartz, Senior Director Oncology Licensing |
||||
|
|
||||
12.15
|
Merck & Co.: Dr Reid Leonard, Executive Director Licensing and External Research |
||||
|
|
||||
12.30
|
Novartis Pharma: Dr. Jennifer Griffiths, Head Search and Evaluation, AB |
||||
|
|
||||
12.45
|
Pfizer Inc.: Dr. Robert Bagdorf, Executive Director, Licensing & Development |
||||
|
|
||||
13.15 |
Networking Lunch |
||||
|
|
||||
18.00 |
Close of Conference |
||||